Cargando…
Combination of clinical characteristics and transrectal ultrasound-guided biopsy to predict lobes without significant cancer: application in patient selection for hemiablative focal therapy
PURPOSE: A major limitation of performing hemiablative focal therapy (FT) for prostate cancer (PCa) is the possibility of accompanying significant cancer in the contralateral side of the prostate that is missed on prostate biopsy. We attempted to verify whether clinical and biopsy-related parameters...
Autores principales: | Jung, Jin-Woo, Lee, Byung Ki, Choi, Won Suk, Park, Yong Hyun, Lee, Sangchul, Jeong, Seong Jin, Lee, Sang Eun, Byun, Seok-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Pacific Prostate Society (APPS)
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970988/ https://www.ncbi.nlm.nih.gov/pubmed/24693533 http://dx.doi.org/10.12954/PI.13031 |
Ejemplares similares
-
Clinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin
por: Lee, Jung Keun, et al.
Publicado: (2016) -
Comparison of systematic randomized 12-core transrectal ultrasonography-guided prostate biopsy with magnetic resonance imaging-transrectal ultrasonography fusion-targeted prostate biopsy
por: Song, Byeongdo, et al.
Publicado: (2022) -
Focal lesion at the midline of the prostate on transrectal ultrasonography: take it or leave it?
por: Kim, Junwoo, et al.
Publicado: (2017) -
Hemiablative Focal Low Dose Rate Brachytherapy: A Phase II Trial Protocol
por: Fernandez Ots, Ana, et al.
Publicado: (2016) -
Focal therapy for prostate cancer – index lesion treatment vs. hemiablation. A matter of definition
por: Stabile, Armando, et al.
Publicado: (2019)